Vaccine supply chain bottlenecks eased, drugmakers tell Congress
Three hundred million doses from Pfizer. Three hundred million from Moderna. One hundred million from Johnson & Johnson. One hundred million from Novavax.
The INFORMS Analytics+ Conference showcased how companies are turning advanced analytics and AI into measurable operational results
Fake Hermès Birkin bags and other counterfeit luxury goods are popular not only with people on a budget, but also with those with deeper pockets, a new study suggests.
Researchers from the National University of Singapore analyzed millions of counterfeit purchases by American consumers from more than 24,000 U.S. zip codes on a major cross-border, e-commerce platform. They found that both lower- and higher-income individuals are “significantly more likely” to buy fake luxury items than middle-income consumers, according to a press release by INFORMS on Monday.
A machine learning program that identified patients overdue for colorectal cancer screening helped increase screening rates and was associated with significantly lower mortality, according to new research published in the INFORMS journal Manufacturing & Service Operations Management.
An audio journey of how data and analytics save lives, save money and solve problems.

Jeff Cohen
Chief Strategy Officer
INFORMS
Catonsville, MD
[email protected]
443-757-3565
Explore our resources for multiple topics including:
Three hundred million doses from Pfizer. Three hundred million from Moderna. One hundred million from Johnson & Johnson. One hundred million from Novavax.
When a large corporation puts money into a small startup, huge innovations can result — like the rapid-fire development of a COVID-19 vaccine.
INFORMS, the leading international association for professionals in operations research and analytics, has selected three finalists for the 2021 UPS George D. Smith Prize, which recognizes excellence in preparing students to become practitioners of operations research and analytics.
The U.S. government has invested billions of dollars in manufacturing, used a wartime act dozens of times to boost supplies and yet there’s still not enough covid vaccine on the way to meet demand — or even the government’s own goals for national immunization.
The Centers for Disease Control and Prevention (CDC) order requiring international travelers coming into the U.S. to provide either proof of a negative COVID-19 test within 72 hours of traveling or proof of recovery from COVID-19 makes no sense.

OR/MS Today is the INFORMS member magazine that shares the latest research and best practices in operations research, analytics and the management sciences.
Access OR/MS Today Magazine
Analytics magazine showcases articles and research reports based on big data, AI, machine learning, data analytics and other new-age technologies.
Access Analytics Magazine